Silyamandin

CAS No. 1009565-36-9

Silyamandin( —— )

Catalog No. M31943 CAS No. 1009565-36-9

Silyamandin may have antihepatotoxic and chemopreventive activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 351 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Silyamandin
  • Note
    Research use only, not for human use.
  • Brief Description
    Silyamandin may have antihepatotoxic and chemopreventive activities.
  • Description
    Silyamandin may have antihepatotoxic and chemopreventive activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1009565-36-9
  • Formula Weight
    498.4
  • Molecular Formula
    C25H22O11
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • HBED-CC-tris(tert-bu...

    HBED-CC-tris(tert-butyl ester) is a monovalent variant of HBED-CC, utilized in the synthesis of synthetic radiocompounds based on asymmetric HBED-CC for tumor imaging.

  • TRAP-14

    TRAP-14 (SFLLRNPNDKYEPF) is a synthetic thrombin receptor agonist peptide.

  • PKC ζ pseudosubstrat...

    Inhibitor of protein kinase C (PKC) ζ; attached to cell permeabilisation Antennapedia domain vector peptide. Consists of amino acids 113 - 129 of PKC ζ pseudosubstrate domain linked by a disulphide bridge to the Antennapedia domain vector peptide. The Antennapedia peptide is actively taken up by intact cells, at 4 or 37°C, ensuring rapid and effective uptake of the inhibitor peptide. Once inside the cell, the disulphide bonds are subjected to reduction in the cytoplasm leading to release of the inhibitor peptide. Induces mast cell degranulation by a PKC ζ-independent pathway.